ArticleAnnals of hematology2026
Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease.
Christina Brummer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it